Preventive effects of 125I seeds on benign restenosis following esophageal stent implantation in a dog model

The present study aimed to evaluate the effects of iodine-125 (I-125) seeds on the proliferation of primary esophageal fibroblasts in dogs, and to assess the safety and preventive efficacy of I-125 seed-pre-loaded esophageal stents in benign restenosis following implantation. Primary fibroblasts were cultured with various I-125 seed activities, which were then evaluated using cell proliferation and apoptosis assays as well as cell cycle analysis using Annexin V/propidium iodide (PI) double staining and PI staining. Prior to sacrification, animals were submitted to esophageal radiography under digital subtraction angiography. Esophageal tissues were collected and examined for macroscopic, microscopic and pathological alterations. The results demonstrated a significant and dose-dependent inhibition of fibroblast proliferation and increased apoptosis following exposure to I-125 seeds. G0/G1 fibroblast populations increased in a dose-dependent manner following treatment with I-125 seeds, in contrast to cells in S phase. Four weeks following implantation, a-smooth muscle actin and proliferating cell nuclear antigen expression levels in the experimental group were significantly lower compared with those in the control group; in addition, eight weeks following implantation, esophageal inner diameters were increased in the experimental group. I-125 seeds inhibited proliferation of dog esophageal fibroblasts via cell cycle arrest and apoptosis. In conclusion, I-125 seed-pre-loaded esophageal stents inhibited benign hyperplasia in the upper edge of the stent to a certain extent, which relieved benign restenosis following implantation with a good safety profile.